FORMAC Pharmaceuticals announces collaboration with W. R. Grace & Co.’s Discovery Sciences
10-May-2011
- Belgium
FORMAC will be responsible for the discovery and preclinical development of new small molecule candidate drugs that may benefit from its unique silica based drug delivery approach. The alliance will make use of FORMAC´s proprietary high throughput screening platform for identification of optimal silica-drug combinations. W.R. Grace & Co will provide material expertise, scale-up and commercialization for new optimized materials for drug delivery.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.